Reducing Low-value Care for Trauma Admissions
Launched by LAVAL UNIVERSITY · Feb 15, 2023
Trial Information
Current as of September 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the care that patients receive after experiencing a trauma injury. In Canada, injuries lead to a significant number of health problems and costs, and many patients don’t receive the best possible care when hospitalized. The trial aims to reduce unnecessary tests and procedures that do not provide real benefits to patients, which can cause harm and waste healthcare resources. By examining ways to avoid these low-value practices, the researchers hope to make trauma care more efficient and effective, ultimately benefiting patients and the healthcare system as a whole.
To participate in this trial, you would need to be treated at certain trauma centers in the province of Québec that handle a high volume of patients. The study is open to all adults, but it excludes smaller centers that may not see enough trauma cases. If you are eligible and choose to participate, you can expect to be part of a project that seeks to improve trauma care, making it safer and more resource-efficient for everyone involved.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: All adult level I-III trauma centers in the Trauma Care Continuum of the province of Québec -
- • Exclusion Criteria: Level IV centers (patient volume too low)
- • -
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Québec, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials